Monopar Therapeutics Inc
MNPR
NASDAQ
Biotechnology
$113.04
USD
+2.63 (+2.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $737.90M
Volume 165.7K
Price Target
$105.00 – $119.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $119.00 and a min estimate of $105.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$113.67
+$11.7 vs prior
Implied Upside
+0.6%
+10.3% vs prior
Analyst Covering
3
+1 vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
60%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$3.33 Gap
Median $117.00 vs avg $113.67 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
2 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Kristen Kluska | Cantor Fitzgerald | Hold | Downgraded | 2 days ago | Plus | Plus | Plus |
Jeet Mukherjee | BTIG | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Andres Y. Maldonado | HC Wainwright & Co. | Buy | Reiterated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
ACHV
Achieve Life Sciences Inc
$7.59
▲ +4.7%
NGNE
Neurogene Inc
$36.14
▲ +1.4%
BBOT
BridgeBio Oncology Therapeutics Inc
$9.06
▼ -1.8%
CTMX
CytomX Therapeutics Inc
$3.36
▲ +0.3%
STTK
Shattuck Labs Inc
$7.42
▲ +1.4%
RGNX
Regenxbio Inc
$10.77
▲ +1.0%
RIGL
Rigel Pharmaceuticals Inc
$42.58
▲ +4.4%
IMMX
Immix Biopharma Inc
$10.97
▲ +0.5%